Similarly, Jacoby et al. reported in a retrospective analysis the outcome of CD-19-targeted CAR T-cells in a pediatric population with relapsed B-ALL with CNS involvement. Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.